{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:36:53Z","timestamp":1790757413132,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.metabol.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T00:30:01Z","timestamp":1340757001000},"page":"1238-1241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study"],"prefix":"10.1016","volume":"61","author":[{"given":"Andrew J.","family":"Krentz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"von M\u00fchlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2012.02.001_bb0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/rep.1.00521","article-title":"Adipokines: implications for female fertility and obesity","volume":"130","author":"Mitchell","year":"2005","journal-title":"Reproduction"},{"key":"10.1016\/j.metabol.2012.02.001_bb0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.ijo.0803719","article-title":"The 'beneficial' adipokines in reproduction and fertility","volume":"32","author":"Campos","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2012.02.001_bb0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","article-title":"Narrative review: the role of leptin in human physiology: emerging clinical applications","volume":"152","author":"Kelesidis","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2012.02.001_bb0020","first-page":"1685","article-title":"Leptin is normal in PCOS, an editorial about three \"negative\" papers","volume":"82","author":"Caro","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.02.001_bb0025","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0026-0495(98)90356-0","article-title":"Serum leptin in obese women with polycystic ovary syndrome is correlated with body weight and fat distribution but not with androgen and insulin levels","volume":"47","author":"Vicennati","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2012.02.001_bb0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/humrep\/13.3.535","article-title":"Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?","volume":"13","author":"Gennarelli","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2012.02.001_bb0035","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.fertnstert.2009.06.034","article-title":"Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: study in normal weight, normoinsulinemic patients","volume":"92","author":"Karkanaki","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2012.02.001_bb0040","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/jc.2009-1557","article-title":"High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance","volume":"95","author":"O'Connor","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.02.001_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.metabol.2012.02.001_bb0050","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/GME.0b013e31802cc7ab","article-title":"Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose\u2013effect association with prevalent cardiovascular disease","volume":"14","author":"Krentz","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.metabol.2012.02.001_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2012.02.001_bb0060","doi-asserted-by":"crossref","first-page":"a2968","DOI":"10.1136\/bmj.a2968","article-title":"Defining polycystic ovary syndrome","volume":"338","author":"Balen","year":"2009","journal-title":"Bmj"},{"key":"10.1016\/j.metabol.2012.02.001_bb0065","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/diacare.23.7.912","article-title":"Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women","volume":"23","author":"Goodman-Gruen","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2012.02.001_bb0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/eje.0.1500715","article-title":"The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors","volume":"150","author":"Choi","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2012.02.001_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1470173","article-title":"Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women","volume":"147","author":"Matsubara","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2012.02.001_bb0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2012.02.001_bb0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2012.02.001_bb0090","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.fertnstert.2009.05.039","article-title":"Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotype","volume":"92","author":"Krentz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2012.02.001_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tem.2003.08.002","article-title":"Polycystic ovary syndrome: syndrome XX?","volume":"14","author":"Sam","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.02.001_bb0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.rbmo.2009.05.010","article-title":"Adipose tissue, metabolic syndrome and polycystic ovary syndrome: from pathophysiology to treatment","volume":"19","author":"Garruti","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.metabol.2012.02.001_bb0105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/jc.2010-0130","article-title":"Hyperandrogenism in women with polycystic ovary syndrome persists after menopause","volume":"96","author":"Markopoulos","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2012.02.001_bb0110","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512000595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049512000595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:55:40Z","timestamp":1758426940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049512000595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0026049512000595"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2012.02.001","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2012.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}